Baillo Pilar, Laporta Felix, Martorell Joan, González Paloma, Rebollo Pablo, Moris Joaquín, Rejas Javier, Díaz Silvia
Centro de Atención Primaria Cervera. Cervera. Lleida. España.
Endocrinol Nutr. 2008 Oct;55(8):326-32. doi: 10.1016/S1575-0922(08)72792-X. Epub 2008 Dec 25.
To develop and validate in Spain a test to measure fear of injecting and selftesting HIAT-I in diabetic patients by translating and adapting the original English version of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ).
Forward-backward translations in duplicate were carried out and were revised by an expert and a nonexpert panel. Men and women with type 1 and type 2 diabetes aged more than 18 years old were enrolled in three primary care centers. The Spanish version of the D-FISQ was administered on two separate occasions at a 15-day interval. The trait-anxiety scale of the Stait-Trait Anxiety Inventory (STAI) and five specific questions on glycemic control, insulin injection, pain and worry were administered. Sociodemographic and clinical data were also collected. Feasibility, construct validity, concept validity and reliability were assessed.
A 32-item version of the D-FISQ was developed by an expert panel and was administered to 93 (35 Type 1, 58 Type 2) insulin-treated diabetic patients. Ninetynine per cent of the patients answered all items in 5 minutes (median). Item-total correlation and factor analysis led to an abridged, 19-item version, maintaining the two original dimensions, and explaining 47.4% percent of the total variance: fear of self-injecting (FSI), accounting for 29.5% of the variance, and fear of self-testing (FST), accounting for 17.9%. Test-retest correlation coefficients were 0.85 (FSI) and 0.94 (FST). The correlations between STAI and FSI and FST were not statistically significant (p=0.771). The correlation coefficient between FSI and time under insulin treatment was -0.546 (p=0.023).
We developed a newrecalibrated version of the Spanish D-FISQ called the MIAT-D. The feasibility, dimensionality, construct validity and reliability of this questionnaire were accurate. The concept validity of this test should be explored in further studies.
通过翻译和改编糖尿病注射与自我检测恐惧问卷(D-FISQ)的原始英文版,在西班牙开发并验证一种用于测量糖尿病患者注射及自我检测恐惧HIAT-I的测试。
进行了一式两份的前后向翻译,并由一个专家小组和一个非专家小组进行修订。在三个初级保健中心招募了年龄超过18岁的1型和2型糖尿病男性和女性患者。D-FISQ的西班牙语版本在两个不同时间间隔15天进行施测。施测了状态-特质焦虑量表(STAI)的特质焦虑量表以及关于血糖控制、胰岛素注射、疼痛和担忧的五个特定问题。还收集了社会人口统计学和临床数据。评估了可行性、结构效度、概念效度和信度。
一个专家小组开发了一个32项版本的D-FISQ,并施测于93名(35名1型,58名2型)接受胰岛素治疗的糖尿病患者。99%的患者在5分钟内(中位数)回答了所有项目。项目-总分相关和因子分析得出一个简化的19项版本,保留了两个原始维度,解释了总方差的47.4%:自我注射恐惧(FSI),占方差的29.5%,自我检测恐惧(FST),占方差的17.9%。重测相关系数分别为0.85(FSI)和0.94(FST)。STAI与FSI和FST之间的相关性无统计学意义(p = 0.771)。FSI与胰岛素治疗时间之间的相关系数为-0.546(p = 0.023)。
我们开发了一个新的重新校准的西班牙文D-FISQ版本,称为MIAT-D。该问卷的可行性、维度、结构效度和信度是准确的。该测试的概念效度应在进一步研究中探索。